NCT01466036
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Carcinoid Tumor
Explore clinical trials studying Carcinoid Tumor. Study availability and eligibility vary by location and protocol.
68 public trials
11 recruiting studies
Carcinoid Tumor trial results
NCT02399215
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT02318784
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
- Locations
-
- Rocky Mountain Cancer Center Denver, Colorado, United States
- Florida Cancer Specialists Fort Myers, Florida, United States
- Florida Hospital Cancer Institute Orlando, Florida, United States
- Florida Cancer Specialists - North St. Petersburg, Florida, United States
NCT01782443
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +11 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00442533
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +19 more
- Locations
-
- Excel Diagnostic Imaging Clinics Houston, Texas, United States
- St. Lukes Episcopal Hospital Houston, Texas, United States
NCT01253161
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoid Tumors, +12 more
- Locations
-
- Stanford Cancer Institute Stanford, California, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT03817866
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +25 more
- Locations
-
- Stanford University Medical Center Palo Alto, California, United States
- Mayo Clinic Rochester, Minnesota, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Charité - Universitätsmedizin Berlin Berlin, Germany
Completed
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
NCT00774930
- Conditions
- Adenocarcinoma, Carcinoid Syndrome, Carcinoid Tumor, +17 more
- Locations
-
- VA Greater Los Angeles Health Care System Los Angeles, California, United States
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- Stanford Cancer Center Stanford, California, United States
- Cedars Sinai Outpatient Cancer Center West Hollywood, California, United States
NCT01619865
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoid Tumors, +14 more
- Locations
-
- University of Iowa Health Care Iowa City, Iowa, United States
NCT01789281
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +7 more
- Locations
-
- Hematology Oncology Services of Arkansas SC Little Rock, Arkansas, United States
- Rocky Mountain Cancer Centers SC Greenwood Village, Colorado, United States
- Stamford Hospital Stamford, Connecticut, United States
- H Lee Moffitt Cancer Center and Research Institute SC-2 Tampa, Florida, United States